2022 annual financial data

Arcutis Biotherapeutics 2022 Net margin

Direct answer

Net margin was -8,449.76%.

Operating income was -301,627,000 USD and net income was -311,458,000 USD.
Operating cash flow was -257,715,000 USD.

Get free Arcutis Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
3,686,000 USD
Operating income
-301,627,000 USD
Net income
-311,458,000 USD
Operating cash flow
-257,715,000 USD